July 13, 2022
Chronic Myelomonocytic Leukemia: 2022 Update on Diagnosis, Risk Stratification, and Management BookmarkGeorge Lundberg, MD
Written for oncology healthcare professionals, this article from the American Journal of Hematology covers the best new therapies for chronic myelomonocytic leukemia in 2022.
January 31, 2022
NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma BookmarkGeorge Lundberg, MD
The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).
July 28, 2021
Latest Advances in the Management of Classical Hodgkin Lymphoma: The Era of Novel Therapies BookmarkGeorge Lundberg, MD
This academic review paper from Blood Cancer Journal outlines many recent advances in the treatment of Hodgkin lymphoma, including for the 15-30% of patients who do not respond or relapse after conventional treatment.